Drug intelligence / Profile preview

Peiyuan Tongbi

Development stage
Unknown
Lead developer
Lianyungang Runzhong
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Peiyuan Tongbi is a traditional Chinese medicine (TCM) formulation used primarily for the treatment of joint diseases, particularly knee osteoarthritis. It is available in various forms such as ointment and capsules. The product is classified as an herbal medicine and has been approved for use in China since December 2017 for joint diseases. Clinical studies suggest that it may reduce joint swelling, inhibit synovial epithelial and fiber hyperplasia, decrease inflammatory cell infiltration, and alleviate articular cartilage damage. Its mechanism of action appears to involve lowering serum levels of pro-inflammatory cytokines such as IL-1 and TNF-α[1][3]. The developer and manufacturer is Shandong Province Runzhong Pharmaceutical Co., Ltd.

Brand names
Peiyuan Tongbi
Other names
Peiyuan Tongbi ointmentPeiyuan Tongbi capsule
02

Targets

IL1R1 (Interleukin-1 Receptor Type 1)

Beyond the preview

Go deeper on Peiyuan Tongbi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peiyuan Tongbi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call